Table 3.
Detection results for clinical specimens
| Single infection | Co-infection | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number | Rate (%) | Real-time PCR/RT-PCR results | Sequencing results | Measures of agreement Kappa values | Number | Rate (%) | Real-time PCR/RT-PCR results | Sequencing results | Measures of agreement Kappa values | ||
| MDV | 26 | 8.7 % | 26 | 26 | 1 (p < 0.001) | MDV + ALV-A | 4 | 1.3 % | 4 | 4 | 1 (p < 0.001) |
| ALV-A | 6 | 2.0 % | 6 | 6 | 1 (p < 0.001) | MDV + ALV-J | 25 | 8.3 % | 25 | 25 | 1 (p < 0.001) |
| ALV-B | 2 | 0.7 % | 2 | 2 | 1 (p < 0.001) | ALV-B + ALV-J | 1 | 0.4 % | 1 | 1 | 1 (p < 0.001) |
| ALV-J | 21 | 7.0 % | 21 | 21 | 1 (p < 0.001) | MDV + ALV-J + REV | 6 | 2 % | 6 | 6 | 1 (p < 0.001) |
| REV | 15 | 5 % | 15 | 15 | 1 (p < 0.001) | MDV + CIAV | 5 | 1.6 % | 5 | 5 | 1 (p < 0.001) |
| IBDV | 17 | 5.7 % | 17 | 17 | 1 (p < 0.001) | MDV + REV | 6 | 2 % | 6 | 6 | 1 (p < 0.001) |
| CIAV | 9 | 3 % | 9 | 9 | 1 (p < 0.001) | ALV-J + REV | 3 | 1.5 % | 3 | 3 | 1 (p < 0.001) |
| ARV | 23 | 7.7 % | 23 | 23 | 1 (p < 0.001) | IBDV + ALV-J | 5 | 1.6 % | 5 | 5 | 1 (p < 0.001) |
| MDV + CIAV + ALV-J | 4 | 1.3 % | 4 | 4 | 1 (p < 0.001) | ||||||
| REV + ARV | 3 | 1 % | 3 | 3 | 1 (p < 0.001) | ||||||
| ALV-J + ARV | 6 | 2 % | 6 | 6 | 1 (p < 0.001) | ||||||
| ALV-J + IBDV | 3 | 1 % | 3 | 3 | 1 (p < 0.001) | ||||||